Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 12/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 11/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 11/20 | 0.43 |
| ▸ | CYP17A1 | P05093 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23437639 | 0.84 | CYP3A4 (0.44) | CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL21362325 | 0.83 | CYP11B1 (0.40) | CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL23437641 | 0.81 | CYP19A1 (0.46) | CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL822818 | 0.79 | CYP11B1 (0.54) | CYP3A4CYP19A1CYP11B1CYP11B2MEN1 | |
| SCHEMBL30843246 | 0.79 | CYP11B1 (0.54) | CYP3A4CYP19A1CYP11B1CYP11B2MEN1 | |
| SCHEMBL20732632 | 0.76 | CYP19A1 (0.54) | CYP3A4CYP19A1CYP11B1CYP11B2MEN1 | |
| SCHEMBL280225 | 0.73 | IDO1 (0.49) | CYP3A4CYP19A1CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL21949232 | 0.73 | KDM4E (0.42) | CYP3A4MEN1TSHRKMT2AAHR | |
| SCHEMBL21362350 | 0.72 | NOS2 (0.39) | CYP3A4CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL12610079 | 0.70 | AHR (0.49) | CYP3A4MEN1KMT2AAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190288223-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190288223-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | TPO, RPLP0, RPS10 | CYP3A4 1873/4885CYP19A1 2501/4885CYP11B1 1731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.